Modifying T Cell Receptor Improves Targeted Cancer Therapy

Researchers engineered T cells to be more efficient and precise in their ability to kill prostate cancer cells. T cell receptors are modified to improve durability of the bond with cancer cells. The post Modifying T Cell Receptor Improves Targeted Cancer Therapy appeared first on GEN - Genetic Engineering and Biotechnology News .